You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 184 Discovery, cloning and functional validation of a neoantigen specific patient derived TCR on the berkeley lights platform, with implications in personalized cancer immunotherapy

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cell Therapies
184 Discovery, cloning and functional validation of a neoantigen specific patient derived TCR on the berkeley lights platform, with implications in personalized cancer immunotherapy
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Valdez J, Stadler G, Lin P(, et al
184 Discovery, cloning and functional validation of a neoantigen specific patient derived TCR on the berkeley lights platform, with implications in personalized cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0184